British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

In the chip sector, Broadcom (AVGO), Micron (MU), AMD (AMD), and Intel (INTC) traded lower last week. Traders took profits in ...

In the entertainment sector, Disney (DIS) is another winning stock. The firm reported revenue growth of 6.3% Y/Y to $22.57 ...

Within 10 years of Crohn's disease diagnosis, up to 50% of people will require surgery, with ileocaecal or ileocolonic resection being the most common procedure.1 Surgery is not curative and disease ...

AstraZeneca moved the other way with a decline of 113p to 9865p, while housebuilders Persimmon and Taylor Wimpey lost about 0 ...

An analysis of antibiotic sales data from 67 countries from 2016-2023 shows a decrease in consumption in high-income countries countered by an increase in middle-income countries ...

“Using Llama models running on Cerebras Inference, GSK is developing innovative AI applications, such as intelligent research ...

The Blue Devils, which lost in a 77-72 nailbiter against Kentucky last week, dropped a few spots in the latest rankings.

Jake Paul’s unanimous victory over former heavyweight champion Mike Tyson might have been disappointing from a competitive ...

If Kennedy is confirmed, we may lower our US vaccine sales estimates, although we don’t think reductions would be ...

Critics say that, if RFK Jr. is made secretary of the HHS, a radical antiestablishment medical movement with roots in past centuries would take power.

The FTSE 100 firm said it still expects to earn between £550million and £570million in adjusted operating profits this year, ...